StockNews.com lowered shares of Transcat (NASDAQ:TRNS – Free Report) from a hold rating to a sell rating in a research report report published on Wednesday morning.
Several other equities analysts have also recently weighed in on TRNS. Craig Hallum lifted their target price on Transcat from $113.00 to $125.00 and gave the company a “buy” rating in a research note on Thursday, December 12th. HC Wainwright reduced their price target on Transcat from $126.00 to $106.00 and set a “buy” rating for the company in a report on Wednesday, January 29th. Northland Securities reiterated a “market perform” rating and set a $85.00 price target (down from $110.00) on shares of Transcat in a report on Wednesday, January 29th. Finally, Oppenheimer lowered Transcat from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 29th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Transcat currently has an average rating of “Hold” and a consensus target price of $111.50.
View Our Latest Report on Transcat
Transcat Price Performance
Transcat (NASDAQ:TRNS – Get Free Report) last released its earnings results on Monday, January 27th. The scientific and technical instruments company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.07. Transcat had a return on equity of 7.43% and a net margin of 6.22%. During the same quarter in the previous year, the firm posted $0.56 EPS. On average, equities research analysts anticipate that Transcat will post 2.3 earnings per share for the current year.
Insider Buying and Selling
In related news, Director Craig D. Cairns bought 1,200 shares of Transcat stock in a transaction that occurred on Friday, January 31st. The stock was purchased at an average cost of $77.02 per share, for a total transaction of $92,424.00. Following the acquisition, the director now owns 1,910 shares in the company, valued at $147,108.20. This trade represents a 169.01 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 2.30% of the company’s stock.
Institutional Inflows and Outflows
Several institutional investors have recently added to or reduced their stakes in the business. Raymond James Financial Inc. bought a new position in Transcat in the 4th quarter worth approximately $2,071,000. Victory Capital Management Inc. increased its position in Transcat by 1.4% in the 4th quarter. Victory Capital Management Inc. now owns 34,710 shares of the scientific and technical instruments company’s stock worth $3,670,000 after buying an additional 480 shares during the period. Charles Schwab Investment Management Inc. increased its position in Transcat by 1.2% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 75,700 shares of the scientific and technical instruments company’s stock worth $8,005,000 after buying an additional 868 shares during the period. Jones Financial Companies Lllp increased its position in Transcat by 686.7% in the 4th quarter. Jones Financial Companies Lllp now owns 354 shares of the scientific and technical instruments company’s stock worth $37,000 after buying an additional 309 shares during the period. Finally, Morgan Dempsey Capital Management LLC bought a new position in Transcat in the 4th quarter worth approximately $143,000. 98.34% of the stock is owned by institutional investors.
About Transcat
Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.
Recommended Stories
- Five stocks we like better than Transcat
- Investing In Automotive Stocks
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- Dividend Payout Ratio Calculator
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.